Adherence to medication for bipolar affective disorder: A qualitative exploration among South Indian patients and their caregivers
Project Description
Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.
Project Duration
2022 - 2025
Project Lead
Salazar Luke Joshua
Authors
Salazar Luke Joshua, Bhuvaneshwari Sethuraman, Malavika Rudrakumar, Megha Ann Mathew
Project Status
completed